523 related articles for article (PubMed ID: 21135509)
1. Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis.
Li M; Krishnaveni MS; Li C; Zhou B; Xing Y; Banfalvi A; Li A; Lombardi V; Akbari O; Borok Z; Minoo P
J Clin Invest; 2011 Jan; 121(1):277-87. PubMed ID: 21135509
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
Zhao Y; Shah DU
Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
[TBL] [Abstract][Full Text] [Related]
3. Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways.
Li M; Li C; Liu YH; Xing Y; Hu L; Borok Z; Kwong KY; Minoo P
J Biol Chem; 2008 Dec; 283(52):36257-64. PubMed ID: 18990706
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis.
Khalil N; Parekh TV; O'Connor RN; Gold LI
Exp Lung Res; 2002; 28(3):233-50. PubMed ID: 11936776
[TBL] [Abstract][Full Text] [Related]
6. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
[TBL] [Abstract][Full Text] [Related]
7. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
8. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.
Jacko AM; Nan L; Li S; Tan J; Zhao J; Kass DJ; Zhao Y
Cell Death Dis; 2016 Nov; 7(11):e2474. PubMed ID: 27853171
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung.
Chen H; Zhuang F; Liu YH; Xu B; Del Moral P; Deng W; Chai Y; Kolb M; Gauldie J; Warburton D; Moses HL; Shi W
Eur Respir J; 2008 Aug; 32(2):285-95. PubMed ID: 18321928
[TBL] [Abstract][Full Text] [Related]
10. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
11. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
12. An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor.
Hoyles RK; Derrett-Smith EC; Khan K; Shiwen X; Howat SL; Wells AU; Abraham DJ; Denton CP
Am J Respir Crit Care Med; 2011 Jan; 183(2):249-61. PubMed ID: 20709822
[TBL] [Abstract][Full Text] [Related]
13. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
[TBL] [Abstract][Full Text] [Related]
14. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
[TBL] [Abstract][Full Text] [Related]
15. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
[TBL] [Abstract][Full Text] [Related]
16. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
18. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
[TBL] [Abstract][Full Text] [Related]
20. TGF-β-responsive myeloid cells suppress type 2 immunity and emphysematous pathology after hookworm infection.
Heitmann L; Rani R; Dawson L; Perkins C; Yang Y; Downey J; Hölscher C; Herbert DR
Am J Pathol; 2012 Sep; 181(3):897-906. PubMed ID: 22901754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
